This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Boston Beer (SAM) Beats on Q3 Earnings & Sales, Ups 2018 View
by Zacks Equity Research
Boston Beer (SAM) tops earnings and sales estimates for third-quarter 2018, backed by solid depletion growth and robust shipment volume.
AB InBev (BUD) Lags on Q3 Earnings & Sales, Retains View
by Zacks Equity Research
AB InBev (BUD) posts earnings and sales miss in third-quarter 2018. Higher commodity prices offset gains from revenue management initiatives, strength in premium brands and cost savings.
5 Consumer Staples Stocks to Buy in a Volatile Market
by Nalak Das
Negative sentiments have dented investor confidence to such an extent that strong third quarter earnings results have failed to instill optimism.
Zacks.com featured highlights include: McCormick, Helen of Troy, Vale and Raytheon
by Zacks Equity Research
Zacks.com featured highlights include: McCormick, Helen of Troy, Vale and Raytheon
Avon Products (AVP) is on Track for Turnaround: Here's Why
by Zacks Equity Research
Avon (AVP) focuses on boosting growth of Representatives, which is a key factor for the success of its direct-selling business. However, investors are wary of its dismal top and bottom-line trends.
4 Stocks to Invest in for Rock-Solid Earnings Acceleration
by Tirthankar Chakraborty
Studies show that a majority of successful stocks witness accelerated earnings before a stock price surge.
Consumer Beauty Unit Hits Coty, Luxury Offers Some Breather
by Zacks Equity Research
Coty's (COTY) Consumer Beauty category has been weak, while the Luxury and Professional Beauty segments have been performing impressively.
Zacks.com highlights: MCBC Holdings, Portland General Electric, Curtiss-Wright, Columbia Sportswear and Helen of Troy
by Zacks Equity Research
Zacks.com highlights: MCBC Holdings, Portland General Electric, Curtiss-Wright, Columbia Sportswear and Helen of Troy
4 Reasons Why Boston Beer (SAM) Must Be in Your Portfolio
by Zacks Equity Research
Boston Beer (SAM) shows resilience, driven by progress on three-point growth plan, focused on cost-saving initiatives, long-term innovation, and revival of Samuel Adams and Angry Orchard brands.
5 Top-Ranked Momentum Picks Using Driehaus Strategy
by Zacks Equity Research
Investors, who have a high level of risk appetite, may think of using the Driehaus strategy
Helen of Troy (HELE) Beats on Q2 Earnings & Sales, Lifts View
by Zacks Equity Research
Helen of Troy's (HELE) top and bottom lines grow year over year and top estimates in the second quarter of fiscal 2019.
Helen of Troy (HELE) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Helen of Troy (HELE) delivered earnings and revenue surprises of 18.56% and 12.19%, respectively, for the quarter ended August 2018. Do the numbers hold clues to what lies ahead for the stock?
5 Earnings Charts to Kick off Earnings Season
by Tracey Ryniec
Be sure to keep an eye on these bellwether companies this week for clues about the third quarter earnings season.
Helen of Troy (HELE) Q2 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Helen of Troy (HELE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Helen of Troy (HELE) Q2 Earnings?
by Zacks Equity Research
Helen of Troy (HELE) is likely to gain from online strength and Project Refuel program. However, weakness in the Beauty segment is a worry.
5 Reasons Why Helen of Troy Stock Must be in Your Portfolio
by Zacks Equity Research
Helen of Troy (HELE) is likely to keep its stellar show on, evident from its raised earnings outlook for fiscal 2019.
Can Avon's Transformation Updates Aid Representative Growth?
by Zacks Equity Research
Avon (AVP) remains committed to boost growth of Representatives, which is witnessing sluggishness for some time now.
Can Coty's (COTY) Saving Efforts Pare Supply Chain Hurdles?
by Zacks Equity Research
Supply chain disruptions and a weak Consumer Beauty unit weigh on Coty's (COTY) performance. Nevertheless, the company is on track with saving efforts and integration of P&G's Beauty business.
Nu Skin Stock Up 33% in a Year, Sales Leaders a Major Driver
by Zacks Equity Research
Nu Skin (NUS) gains from a sturdy network of sales leaders and customers. These have driven growth in most regional segments.
Smucker (SJM) Misses on Q1 Earnings & Sales, Trims '19 View
by Zacks Equity Research
Excluding the Ainsworth acquisition, Smucker's (SJM) top-line performance in Q1 remains dismal due to lower net price realization.
Clorox (CLX) Surges 24% in 3 Months: More Room to Run?
by Zacks Equity Research
Clorox's (CLX) is moving up the charts thanks to its robust earnings surprise history and progress on the 2020 Strategy.
Coty (COTY) Q4 Earnings In Line, Sales Miss, Stock Down
by Zacks Equity Research
Coty (COTY) matches earnings estimates for fourth-quarter fiscal 2018 while sales lag. Results gain from strength in Luxury and Professional Beauty segments, offset by weakness in Consumer Beauty.
Tyson Foods Protein Production to Gain From Keystone Deal
by Zacks Equity Research
Tyson Foods (TSN) announces intentions to acquire Keystone Foods. This is expected to be a valuable addition to the company's rich protein-products portfolio.
Strong Brands & Regions Aid Estee Lauder in (EL) Q4 Earnings
by Zacks Equity Research
Solid brand and regional performances drive Estee Lauder's (EL) Q4 results. Travel and online sales were also strong.
Kimberly-Clark (KMB) Banks on FORCE Program to Offset Costs
by Zacks Equity Research
Kimberly-Clark's robust cost-saving efforts and regular innovation help the company outperform the industry over the past three months.